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Abstract
Objective—To evaluate the variation in all-cause attrition (mortality and loss to follow-up 
(LTFU)) among HIV-infected individuals in Botswana by health district during the rapid and 
massive scale-up of the National Treatment Program.
Methods—Analysis of routinely collected longitudinal data from 226,030 patients who received 
ART through the Botswana National HIV/AIDS Treatment Program across all 24 health districts 
from 2002 to 2013. A time-to-event analysis was used to measure crude mortality and loss to 
follow-up rates (LTFU). A marginal structural model was used to evaluate mortality and LTFU 
rates by district over time, adjusted for individual-level risk factors (e.g., age, gender, baseline 
CD4, year of treatment initiation, and antiretroviral regimen).
Results—Mortality rates in the districts ranged from the lowest 1.0 (95% CI 0.9–1.1) in Selibe-
Phikwe, to the highest 5.0 (95% CI 4.0–6.1), in Mabutsane. There was a wide range of overall 
LTFU across districts, including rates as low as 4.6 (95% CI 4.4–4.9) losses per 100 person-years 
in Ngamiland, and 5.9 (95% CI 5.6–6.2) losses per 100 person-years in South East, to rates as high 
as 25.4 (95% CI 23.08–27.89) losses per 100 person-years in Mabutsane and 46.3 (95% CI 43.48–
49.23) losses per 100 person-years in Okavango. Even when known risk factors for mortality and 
LTFU were adjusted for, district was a significant predictor of both mortality and LTFU rates
Conclusion—We found statistically significant variation in attrition (mortality and LTFU) and 
data quality among districts. These findings suggest that district-level contextual factors affect 
retention in treatment. Further research needs to investigate factors that can potentially cause this 
variation.
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Introduction
Rapid expansion of HIV testing and counseling, and the scale-up of antiretroviral therapy 
(ART) has significantly changed the course of the HIV epidemic. Health systems, however, 
have had a hard time coping with the scale and speed of this rapid expansion, mainly due to 
limited resources, particularly health professionals, poorly-designed service delivery, supply 
chain management and under-developed monitoring and evaluation capacity[1].
In 2002, Botswana was one of the first countries in sub-Saharan Africa to provide free 
antiretroviral therapy (ART) for eligible citizens, and has been a leader in spurring an 
effective regional and global response to the epidemic. The Botswana National ART 
Program, called Masa (the Setswana word for “new dawn”), has achieved universal coverage 
of ART by providing care to more than 95% of individuals who have tested positive and 
qualify for treatment in the country[2], serving more than 250,000 patients [3]. Through 
proactive policies and programs around HIV/AIDS, Botswana has made major gains and has 
laid the foundation for continued progress against the epidemic. However, the overall 
effectiveness of the program has been adversely affected by high levels of attrition across the 
HIV care continuum [4, 5].
Evaluation of the Masa Program shows improved survival [4] and quality of life of HIV-
infected patients enrolled in the program [6]. However, there is scarce information about the 
performance of the Program at sub-national level. There is ample evidence indicating 
substantial geographical differences in health inequality both between and within countries 
[7, 8]. People living in places with access to better care consequently have better health 
outcomes [9, 10]. For example, in the United States, despite considerable overall mortality 
decline among HIV-infected patients over the last two decades, studies show growing 
socioeconomic and racial inequality in HIV mortality [11, 12]. Similar patterns of mortality 
among the HIV-infected population were found in sub-Saharan Africa. One study in South 
Africa found elevated risk of mortality in rural areas as compared to urban areas [13].
Examining geographic inequality is important as it may help policy makers reduce 
contextual barriers to healthcare for all patients, particularly for HIV-infected individuals. 
Moreover, this kind of study can shed light on variation in access and resources available to 
healthcare services in different locations. There is a need for a comprehensive analysis 
measuring the impact of an ART program while simultaneously accounting for individual 
predictors of disease progression and the context in which these programs operate. Given 
inequality in health and mortality has long been an important area of public health research, 
this study aimed to examine whether individuals receiving ART in different health districts1 
1Botswana is divided into nine administrative districts, which is further divided into 15 councils, including the nine districts councils 
from the nine districts plus some councils from urban or town councils. Each of these 24 subdivisions is considered a health district. 
Henceforth, we will refer to health districts as “districts.”
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in Botswana experience different mortality risk once demographic, immunologic and 
medical variables have been taken into account. Unlike previous studies [7, 14], rather than 
relying on aggregate level data, this analysis used a rich, longitudinal national registry of 
HIV-infected patients collected at the individual level to measure the effect of the place-
based contextual factors on individual outcomes, highlighting how place of residence can 
influence an individual’s health.
Methods
Data source and study population
We used routinely collected data from 226,030 HIV-infected adults aged 18 to 68 enrolled in 
the Masa program to assess inequality in all-cause mortality and loss to follow-up (LTFU) 
among HIV-infected individuals. During the data cleaning process, we removed 620 
individuals’ observations for having clinical records over 90 days after documented death. 
These individuals received ART in 176 healthcare facilities in all 24 health districts across 
Botswana from January 2002 to October 2013. The details of the database have been 
previously described [15].
Primary outcome measures for this analysis were mortality and LTFU. Although active 
tracing for patients late for clinic appointments is recommended, resource limitations 
constrain tracing activities and most documented deaths are passively reported. Those 
considered LTFU could still be in treatment, but because of the failure to enter the data from 
paper forms into electronic database at facilities or because of silent transfers of the patients 
to new facilities the patients could not be tracked down in the electronic database. For this 
reason, it is also necessary to determine the number of patients who are LTFU as they may 
have been patients who died, but the death was not recorded in the system. For this analysis, 
LTFU will be defined as a patient who had not been seen at the clinic 90 days after a missed 
scheduled visit.
Physical access to health facilities is one of the important factors that can influence 
adherence and retention in care. Traditionally, access has been measured by distance or 
travel time to nearest health facility. As we did not have the actual distance travelled to 
access healthcare, we used population density as a proxy for ease of access to care. There is 
a wide variation in population density in Botswana, from 13.8 persons/km2 in the South 
Eastern region to fewer than 1 person/km2 in the Western region [16]. Over the 2001 and 
2011 intercensal period, population density in the South Eastern Region significantly 
increased while in the Northern and Western Region remained stagnant [16]. According to 
Botswana 2011 Census Analytical Report, districts with lower population density have fewer 
health facilities and poor road conditions compared to the districts with higher population 
density, which can restrict residents’ easy access to health facilities [16]. We used HIV 
prevalence in each district in each year as proxy for the potential level of patient volume 
seen at facilities in the district, which can be translated into the level of workload for health 
workers. We used Gaborone, the capital of the country as the reference group.
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We used a person-years (P-Y) approach to analyze event rates. We calculated survival from 
the date of ART initiation until death or the date of the last follow-up. The data were 
censored on the date of the patient’s last follow-up visit. Districts were ranked based on 
unadjusted mortality and LTFU rates in 2004, 2008 and 2012.
This study used a multilevel model to assess the extent that the district where healthcare is 
provided explains mortality among HIV patients controlling for individual-level risk factors. 
We compared odds of death in HIV-infected population among districts using marginal 
structural modeling. We used this technique to address the complex issue of LTFU and 
prevent bias in interpreting the results [17, 18]. Using observed variables, this approach 
allows us to derive a weight for each individual in each time period, i.e., the inverse 
probability of remaining in the study in that interval [19]. Following the literature, the 
stabilized version of inverse probability of LTFU was estimated as a ratio of two predicted 
probabilities from two pooled logistic regression models. The model for the numerator of 
this ratio includes only the baseline covariates, while the denominator includes baseline and 
time-varying covariates [20]. Because the dataset was formatted as one observation per 
person per quarter, we used a pooled logistic regression, which is close to a time-dependent 
covariate Cox regression model [21], to model the probability that each individual was 
treated in each quarter.
Results
Baseline characteristics
Table 1 shows summary statistics for the patient population in the Masa Program. The 
analysis included 687,759 person-years of follow-up time during 2002–2013 from all the 24 
health districts in Botswana. Gaborone has the largest patient population with over 35,000 
individuals or 16% of the patient population. Other districts with high patient populations 
include Francistown, Kweneng East, Tutume, and Selibe-Phikwe. Some districts, namely 
Mabutsane, Okavango, Kgalagadi North and South, and Kweneng West have comparatively 
smaller patient populations, with each representing less than 2% of the total patient 
population (Figure 1). The patient population is 62% female, although within districts it 
ranges from 59% in Francistown, to 79% in Good Hope. The median age is 35 years (inter-
quartile range [IQR] 29–42) overall, with very little variation across districts. The median 
baseline CD4 cell count is 147 cells/mm3 (IQR 79–200). The highest median baseline CD4 
cell count was in Serowe/Palapye district (221 cells/mm3 (IQR 127–410) and the lowest was 
in Tutume (113 cells/mm3 (IQR 58–170).
Table 2 reports cumulative number of death and LTFU among ART enrollees in each district. 
The proportion of the patients died in the program ranges from 12% in Jwaneng Town to 3% 
in Selebe-Phikwe. There is also wide variation with regards to LTFU. South East with 23% 
has the lowest proportion of LTFU, while Mabutsane Sub with 72% has the highest 
proportion of LTFU.The median follow-up time was 26 months across districts (IQR 5–57). 
Ngamiland, Gaborone, Bobirwa and South East have the longest median patient follow-up, 
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each above 33 months, while Kweneng East, Okavango, Serowe/Palapye and Mabutsane 
each had a median follow-up time of 15 months or less.
Mortality—Overall, the crude mortality rate was 2.06 per 100 person-years (95% CI 2.03–
2.10). Table 3 reports the mortality and LTFU rates at different intervals in all Botswana 
districts. Mortality in the first year of treatment was 5.3 deaths per 100 person-years (95% 
CI 5.2–5.4), with a large range in the districts. South East and Selibe-Phikwe had the lowest 
one-year mortality rates at 1.8 deaths per 100 person-years (95% CI 1.5–2.2) and 2.0 per 100 
person-years (95% CI 1.8–2.3), respectively. Mabutsane, Jwaneng, and Good Hope all have 
one-year mortality rates over 10 deaths per 100 person-years. Death in the first three months 
after treatment initiation remains high. Overall, the mortality rate in this time period is 11.8 
deaths per 100 person-years (95% CI 11.5–12.1). South East, Selibe-Phikwe, Lobatse, 
Bobirwa, and Chobe have first-quarter mortality rates of less than 10 deaths per 100 person-
years, while Kweneng West, Kgalagadi South, Jwaneng and Good Hope have mortality rates 
over 20 deaths per 100 person-years in the same period.
Loss to Follow-up—The overall rate of LTFU is 12.47 per 100 person-years (95% CI 
12.38–12.55). Like mortality the rates of LTFU are higher in the first year and the first three 
months after treatment initiation (Table 3). For LTFU this rate was 14.2 losses per 100 
person-years (95% CI 13.8–14.5) in the first three months, and 14.9 losses per 100 person 
years (95% CI 14.7–15.1) in the first year. There was a great range of overall LTFU across 
districts, including rates as low as 4.6 losses per 100 person-years in Kgalagadi North, and 
5.9 losses per 100 person-years in Kgalagadi South, to rates as high as 25.4 losses per 100 
person-years in Kweneng East and 46.3 losses per 100 person-years in Ngamiland. Nine 
districts had LTFU rates over 15 losses per 100 person-years in the first year, while 5 
districts had LTFU rates of less than 10 losses per 100 person-years. Similarly, eight districts 
had LTFU rates higher than the overall rate of 14.2 losses per 100 person-years in the first 
three months, while 7 districts had LTFU rates under 10 losses per 100 person-years.
Table 4 provides crude mortality and LTFU rates, with corresponding rankings for each 
district in 2004, 2008 and 2012, with lower numbers corresponding to higher mortality (or 
LTFU) rates and higher numbers corresponding to lower mortality (or LTFU) rates. In terms 
of mortality, the ranks of certain districts changed substantially over time. Some districts 
maintained their rank, while others had steady increases or decreases in ranks. However the 
largest proportion of districts had rates that decreased or increased between 2004 and 2008, 
but in 2012 returned to ranks more similar as those seen in 2004. For example, Kgalagadi 
North’s and Kweneng East’s mortality rate rank increased over time, while Kgatleng 
mortality rate ranks decreased over time. Serowe/Palapye and Good Hope, at the two ends of 
the mortality rate range, stay steady across these years. Southern is an example of a district 
whose rank greatly increased during 2008, but was relatively low in both 2004 and 2012. 
Inversely, Gantsi is an example of a district that had higher ranks in 2004 and 2012 but a 
much lower rank in 2008.
Table 5 shows results from regression models examining characteristics associated with odds 
of attrition, including mortality and LTFU among HIV patients. Overall, differences by 
district were statistically significant when adjusting for demographic, immunologic and 
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medication variables, including gender, age, baseline CD4 cell count category (0–49;50–
249; 250–499; 500+) ART regimen, in addition to the district level variables of population 
density, and HIV prevalence level. Compared with Gaborone, Good Hope district did not 
have significantly different odds of mortality. Additionally, Mabutsane was omitted due to a 
small number of individuals remaining in the mortality model. Only two districts, 
Francistown and Lobatse had a higher odds ratio of mortality compared with Gaborone 
(odds ratio (OR) 1.47 [95% CI 1.33–1.62] and 1.21 [95% CI 1.04–1.41], respectively). All 
other districts had statistically significantly lower OR of mortality compared with Gaborone. 
When examining the odds of LTFU across districts, Six districts have lower odds of LTFU 
compared with Gaborone ranging from 0.39 to 0.62. The remaining 15 districts each have 
greater odds of LTFU compared with Gaborone..
Discussion
Analysis of medical records from 262,030 patients from 2002 to 2013 revealed significant 
differences in mortality rate among HIV-infected individuals receiving ART in different 
districts, with odds of mortality in many districts higher than Gaborone, the capital and most 
populous district, even after adjusting for patient-level variables, e.g., gender, age, baseline 
CD4 cell categories, duration of treatment, year of initiation, and first-line ART. However, 
when district-level variables, namely population density as a proxy for physical access to 
care and HIV prevalence for facility workload were included, the odds of mortality in almost 
all districts (except for Kgatleng and Jwaneng2) reversed. It seems that contextual factors, 
both inside and outside the health system may play a more important role in the survival of 
patients than expected.
Service availability, specifically physical access to services, is a pivotal component of 
healthcare [22]. Limited physical access to healthcare facilities can partly explain substantial 
differences in mortality rates in the sparsely populated districts in the north and west of the 
country. For example, mortality rates in northern districts, Okavango, Boteti, Tutume, and 
Chobe were the highest whether looking at overall mortality or odds of death controlling for 
all patient-level variables. However, after adjusting for population density and HIV 
prevalence, the odds of mortality were less than that of Gaborone. The patients in these 
districts have to travel long distances to get to a primary hospital or, for those who need 
advanced care, to referral hospitals, namely Princess Marina Hospital in Gaborone and 
Nyangabgwe Referral Hospital in Francistown [23]. That may partially explain the 
significant reduction in odds of mortality in these districts, compared to Gaborone, when 
population density and HIV prevalence were added to model.
Part of this variation in mortality and LTFU across districts could be explained by shortages 
of health professionals, exacerbated by their misdistribution across districts. Botswana, like 
other sub-Saharan African countries, has the lowest doctor and nurse to population ratio in 
the world [24]. ART scale-up needed a multitude of experienced and trained health 
professional [25]. The critical short-age of health personnel was further complicated by 
inequality in geographic distribution [26]. There is a significant variation across health 
2In these two districts, after adding the district-level variables the odds differences became statistically significant.
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districts with regards to the distribution of health professionals[26]. After the influx of 
patients seeking ART during scale-up, districts with a low healthcare-professional-to-patient 
ratio probably experienced higher mortality and LTFU among HIV patients. Further research 
is needed to evaluate this hypothesis.
Large-scale patient enrollment in chronic-care services in a developing country like 
Botswana has significantly added to the burden on services and providers. Particularly, 
districts with higher HIV prevalence have to handle many more patients than those with 
lower prevalence, with no evidence of the resources being distributed according to HIV 
prevalence in a district. The quality of care in districts with higher prevalence could have 
been adversely affected with an ever-increasing number of patients using limited resources, 
such as trained personnel, diagnostic and therapeutic equipment, medication, and intensive 
care services. The increasing workload due to higher prevalence may explain differences in 
odds of mortality between Gaborone and other districts. ks of
While some of these mortality rate differences can be, at least partially, explained, some 
cases are quite baffling. For example, the mortality differentials between Gaborone and 
Francistown, the two largest urban centers in the country, each one housing one of the two 
tertiary hospitals in the country, are hard to explain. HIV prevalence in Francistown in 2004, 
2008 and 2013 was 24.6, 23.1 and 23.1, respectively, while in the same years HIV 
prevalence in Gaborone was 18.3, 17.1 and 16.2. Given the fact that case fatality rate in both 
cities is 7%, controlling for the patient- and district-level variables, the odds of a patient 
dying in Francistown are 30% higher than in Gaborone. Conversely given that the median 
baseline CD4 over the last 10 years in Gaborone and Francistown were almost the same (121 
and 123 cells/mm3, respectively), it seems that superior adherence to medical protocols, or 
better care in Gaborone, may better explain the differences rather than does earlier screening 
or entry into care. Another possible reason for the differences is that more patients in 
advanced-stages of the disease may have been referred from neighboring districts to 
Francistown than to Gaborone.
As for LTFU, we also found significant variation between districts. However, in the 
regression model adding district-level variables reduced the odds, but did not change the 
direction of the odds in most of the districts. We could not detect a correlation between the 
geographical location of the districts and LTFU rates. For instance, Ngamiland and Tutume 
are both in the northern part of the country, with LTFU rates at 4.6 and 18.3 per 100 P-Y, 
respectively; or Bobirwa and Mahalapye are both in the central-eastern part of the country 
with LTFU rate of 5.9 and 18.1 per 100 P-Y, respectively. It seems that LTFU rates have 
much to do with data quality. For example, in Okavango and Mabutsane patient’s records 
entry into the electronic database gradually dwindled after 2008, consequently, it seems that 
these districts have a high rate of LTFU. Most likely many of those patients are still in care, 
however, because of unclear reasons their medical records are not captured in the national 
database or they have been transferred to the clinics closer to their residence and their 
medical records could not be linked.
One of the limitations of this study was data quality. Variable quality of data across districts 
could explain part of the total variation in health outcome. There are some facilities 
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equipped with the hardware and software whose data have not been captured in the 
electronic database. Some facilities have been reporting only demographic data and fail to 
report the laboratory results or prescription drug regimens of clients. Even the reporting, or 
lack thereof, was not consistent, and fluctuates over time.
Our study poses the question why the same guidelines and medication regimens for the 
patients across districts can result in different outcomes? Why do mortality rates vary among 
districts? The attrition rate (retention and survival) has been increasingly used as a yardstick 
to assess the long-term success of large scale ART programs [16]. The fact that this study 
found significant attrition in-equality across districts suggests that the expanding ART 
program might not have effective management and sufficient resources in some districts to 
adequately support adherence and retention. Policy makers need to consider investing in 
building effective health systems as the paradigm shifts from emergency response to chronic 
disease management [1].
Our findings support earlier work identifying inequality at subnational and cross-national 
levels [11, 14]. The elimination of inequality in health outcome, particularly among HIV-
infected individuals should be a priority of the Ministry of Health. Health officials should 
focus on targeted support to districts with disproportionately high attrition rate. Place of 
residence and subsequently where individuals receive care should be considered as 
important components of any national analysis, as there are many contextual factors inside 
and outside the healthcare delivery system that can cause variation in outcomes. While part 
of the variation found in this study is due to data quality, part of it may be due to scarcity 
and management of resources and infrastructure at district- and facility-level, and part to 
factors beyond the healthcare system, e.g., poverty, infrastructure, etc. [29] Future studies 
need to examine the existing ART delivery system and human resources components to 
identify the underlying factors at district- and facility-level. The findings of this study can 
help both researchers and policy-makers by advising them consider contextual factors as 
well individual-level factors while taking steps to address the underlying causes of variation 
in mortality and LTFU outcomes of patients on ART.
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Table 5
The Multilevel Logistic Regression Model Describing the Association between Districts and Attrition Rates.
District Mortality 95% CI LTFU 95 % CI
Bobirwa 0.28*** (0.21– 0.39) 0.53*** (0.46– 0.61)
Boteti 0.52*** (0.37– 0.73) 1.77*** (1.54– 2.06)
Chobe 0.20*** (0.14– 0.29) 1.60*** (1.38– 1.88)
Francistown 1.47*** (1.31– 1.60) 4.34*** (4.09– 4.55)
Gaborone - –
Gantsi 0.25*** (0.17– 0.35) 1.37*** (1.18– 1.57)
GoodHope 0.87 (0.60– 1.30) 1.47*** (1.26– 1.76)
Jwaneng 0.28* (0.07– 1.16) 1.1 (0.77– 1.57)
Kgalagadi South 0.23*** (0.10– 0.51) 0.77* (0.58– 1.04)
Kgalagadi North 0.28*** (0.13– 0.62) 0.53*** (0.38– 0.76)
Kgatleng 0.14*** (0.08– 0.26) 1.42*** (1.24– 1.68)
Kweneng East 0.30*** (0.22– 0.41) 1.89*** (1.64– 2.17)
Kweneng West 0.36*** (0.20– 0.64) 1.79*** (1.46– 2.14)
Lobatse 1.21** (1.04– 1.40) 1.51*** (1.43– 1.61)
Mabutsane (omitted) 13.34*** (6.85– 30.95)
Mahalapye 0.28*** (0.20– 0.38) 1.98*** (1.72– 2.26)
Masunga 0.19*** (0.13– 0.26) 2.37*** (2.06– 2.75)
Ngamiland 0.25*** (0.18– 0.34) 0.39*** (0.34– 0.46)
Okavango 0.50*** (0.33– 0.77) 3.25*** (2.83– 3.78)
Selibe-Phikwe 0.61*** (0.53– 0.70) 2.96*** (2.79– 3.16)
Serowe/Palapye 0.06*** (0.03– 0.12) 0.43*** (0.34– 0.55)
South East 0.38*** (0.28– 0.51) 0.46*** (0.41– 0.52)
Southern District 0.20*** (0.14– 0.27) 0.62*** (0.54– 0.72)
Tutume 0.38*** (0.27– 0.53) 3.28*** (2.85– 3.79)
1)- Level of statistical significance: *0.1 **0.05 ***0.001
2)-Adjusted for patient-level variables: gender, age, baseline CD4, follow-up time after treatment initiated, ARV medications at treatment initiation, 
year treatment was initiated and district level variables: HIV prevalence and population density in each year. Gaborone, the capital, is the reference.
3)- Models are weighted (IPW) to account for LTFU.
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